Aller au contenu principal
Retour à l'annuaire
Rhumatologue

Docteur GERARD KAPLAN

RPPS 10000103688
🎓 1 thèse dirigée

Diplômes

🎓 DES & spécialité ordinale

  • Rhumatologie (SM)

📚 CES (Certificat d'Études Spéciales)

  • CES Rhumatologie

🎓 Diplômes

  • DE Docteur en médecine

Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.

Direction de thèses

🎓 1 thèse dirigée

Source theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).

Lieu de consultation

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

📊 Comprendre le remboursement

Prendre rendez-vous & contact

🗓 Trouver sur Doctolib📇 Ajouter à mes contacts

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

  • 1
    Successful aging: predictors and associated activities

    American journal of epidemiology · 1996

    📚 231 citations🎯 RCR 10.10Top 3% NIH🔓 Open Access📄 PDF gratuit ↗
  • 2
    Vasculitides associated with malignancies: analysis of sixty patients

    Arthritis and rheumatism · 2007

    📚 206 citations🎯 RCR 7.07Top 4% NIH
    Lire l'abstract Crossref ↓

    AbstractObjectiveTo describe characteristics and outcomes of vasculitides associated with malignancies.MethodsThe requirement for inclusion in this retrospective, 10‐year study was development of vasculitis in patients with a progressing malignancy. Malignancies secondary to immunosuppressants used to treat vasculitis were excluded. The main characteristics of vasculitides were analyzed and compared according to the type of malignancy.ResultsSixty patients were included (male/female sex ratio 2.53, mean age 62.4 years). Mean followup duration was 45.2 months. Vasculitides were cutaneous leukocytoclastic (45%), polyarteritis nodosa (36.7%), Wegener's granulomatosis (6.7%), microscopic polyangiitis (5%), and Henoch‐Schönlein purpura (5%). Malignancies were distributed as follows: hematologic in 63.1%, myelodysplastic syndrome (MDS) in 32.3%, lymphoid in 29.2%, and solid tumor in 36.9%. Vasculitides were diagnosed concurrently with malignancy in 38% of the cases. Manifestations of vasculitides were fever (41.7%), cutaneous involvement (78.3%), arthralgias (46.7%), peripheral neuropathy (31.7%), renal involvement (23.3%; 11.7% glomerulonephritis, 11.7% microaneurysms, 6.7% renal insufficiency), and antineutrophil cytoplasmic antibody (20.4%). Vasculitis treatments were corticosteroids (78.3%) and immunosuppressant(s) (41.7%). Vasculitis was cured in 65% of patients, but 58.3% died, with 1 death secondary to vasculitis. Independent of subtype, patients with vasculitides associated with MDS more frequently had renal manifestations (P = 0.02) and steroid dependence (P = 0.04) and achieved complete remission less often (P = 0.04) than patients with vasculitides associated with other malignancies. Patients with vasculitides associated with a solid tumor more frequently had peripheral neurologic involvement (P = 0.05). Patients with vasculitides associated with lymphoid malignancy had less frequent arthralgias (P = 0.01) and renal involvement (P = 0.02).ConclusionVasculitides occurring during malignancies present distinctive features according to the vasculitis subtype and nature of the malignancy.

  • 3
    Acupuncture for osteoarthritis of the knee: a systematic review

    Arthritis and rheumatism · 2001

    📚 163 citations🎯 RCR 5.88Top 6% NIH

Publications scientifiques (50) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Transversal30

▼

csDMARDs3

▼

Revue / méta-analyse3

▼

Revue générale3

▼

Sjögren3

▼

Essai clinique2

▼

Santé mentale / fatigue2

▼

Sclérodermie2

▼

Vraie vie / RWE2

▼

Anti-TNF1

▼

Épidémiologie & registres1

▼

Pédiatrie1

▼

Qualité de vie / PROMs1

▼

Spondyloarthrite1

▼

Partager cette fiche

in LinkedIn🟢 WhatsApp✉ Email

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.